Pieter Populaire

Pieter Populaire

Auto-generated profile, based on publicly available information

Pieter Populaire

KU Leuven, Laboratory of Experimental Radiotherapy, Leuven, Belgium; UZ Leuven, Department of Radiation Oncology, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2022 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
CDCamille Draguet
Camille Draguet
AMAna Maria Barragan Montero
Ana Maria Barragan Montero
MVMacarena Chocan Vera
Macarena Chocan Vera
MTMelissa Thomas
Melissa Thomas
PPPieter Populaire
Pieter Populaire
ESEdmond Sterpin
Edmond Sterpin

10 October 2024 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
CDC Draguet
C Draguet
PPP Populaire
P Populaire
MVM Chocan Vera
M Chocan Vera
AFA Fredriksson
A Fredriksson
KHK Haustermans
K Haustermans
ESEdmond Sterpin
Edmond Sterpin
Objective. To demonstrate the feasibility of integrating fully-automated online adaptive proton therapy strategies (OAPT) within a commercially available treatment planning system and underscore what limits their clinical implementation. These strategies leverage existing deformable image registration (DIR) algorithms and state-of-the-art deep learning (DL) networks for organ segmentation and proton dose prediction. Approach. Four OAPT strategies featuring automatic segmentation and robust optimization were evaluated on a cohort of 17 patients, each undergoing a repeat CT scan. (1) DEF-INIT combines deformably registered contours with template-based optimization. (2) DL-INIT, (3) DL-DEF, and (4) DL-DL employ a nnU-Net DL network for organ segmentation and a controlling ROIs-guided DIR algorithm for internal clinical target volume (iCTV) segmentation. DL-INIT uses this segmentation alongside template-based optimization, DL-DEF integrates it with a dose-mimicking (DM) step using a reference deformed dose, and DL-DL merges it with DM on a reference DL-predicted dose. All strategies were evaluated on manual contours and contours used for optimization and compared with manually adapted plans. Key dose volume metrics like iCTV D98% are reported. Main results. iCTV D98% was comparable in manually adapted plans and for all strategies in nominal cases but dropped to 20 Gy in worst-case scenarios for a few patients per strategy, highlighting the need to correct segmentation errors in the target volume. Evaluations on optimization contours showed minimal relative error, with some outliers, particularly in template-based strategies (DEF-INIT and DL-INIT). DL-DEF achieves a good trade-off between speed and dosimetric quality, showing a passing rate (iCTV D98% > 94%) of 90% when evaluated against 2, 4 and 5 mm setup error and of 88% when evaluated against 7 mm setup error. While template-based methods are more rigid, DL-DEF and DL-DL have potential for further enhancements with proper DM algorithm tuning. Significance. Among investigated strategies, DL-DEF and DL-DL demonstrated promising within 10 min OAPT implementation results and significant potential for improvements.

29 August 2023 in Acta Oncologica
Verified
Journal Article
Closed access
PPPieter Populaire
Pieter Populaire
GDGilles Defraene
Gilles Defraene
PNPhilippe Nafteux
Philippe Nafteux
LDLieven Depypere
Lieven Depypere
JMJohnny Moons
Johnny Moons
KHKarin Haustermans
Karin Haustermans
Trimodality treatment, i.e., neoadjuvant chemoradiotherapy (nCRT) followed by surgery, for locally advanced esophageal cancer (EC) improves overall survival but also increases the risk of postoperative pulmonary complications. Here, we tried to identify a relation between dose to functional lung volumes (FLV) as determined by 4D-CT scans in EC patients and treatment-related lung toxicity. All patients with EC undergoing trimodality treatment between 2017 and 2022 in UZ Leuven and scanned with 4D-CT-simulation were selected. FLVs were determined based on Jacobian determinants of deformable image registration between maximum inspiration and expiration phases. Dose/volume parameters of the anatomical lung volume (ALV) and FLV were compared between patients with versus without postoperative pulmonary complications. Results of pre- and post-nCRT pulmonary function tests (PFTs) were collected and compared in relation to radiation dose. Twelve out of 51 EC patients developed postoperative pulmonary complications. ALV was smaller while FLV10Gy and FLV20Gy were larger in patients with complications (respectively 3141 ± 858mL vs 3601 ± 635mL, p = 0.025; 360 ± 216mL vs 264 ± 139mL, p = 0.038; 166 ± 106mL vs 118 ± 63mL, p = 0.030). No differences in ALV dose-volume parameters were detected. Baseline FEV1 and TLC were significantly lower in patients with complications (respectively 90 ± 17%pred vs 102 ± 20%pred, p = 0.033 and 93 ± 17%pred vs 110 ± 13%pred, p = 0.001), though no other PFTs were significantly different between both groups. DLCO was the only PFT that had a meaningful decrease after nCRT (85 ± 17%pred vs 68 ± 15%pred, p < 0.001) but was not related to dose to ALV/FLV. Small ALV and increasing FLV exposed to intermediate (10 to 20 Gy) dose are associated to postoperative pulmonary complications. Changes of DLCO occur during nCRT but do not seem to be related to radiation dose to ALV or FLV. This information could attribute towards toxicity risk prediction and reduction strategies for EC.

31 January 2025 in Physics and Imaging in Radiation Oncology
Verified
Journal Article
Open access
PHPascal Herbst
Pascal Herbst
CDCamille Draguet
Camille Draguet
AMAna Maria Barragan Montero
Ana Maria Barragan Montero
EVElena Borderías Villarroel
Elena Borderías Villarroel
MVMacarena Chocan Vera
Macarena Chocan Vera
ESEdmond Sterpin
Edmond Sterpin
Proton therapy for oesophageal cancer is administered over multiple fractions, based on a single pre-treatment image. However, anatomical changes can lead to the deterioration of the treatment plan, necessitating manual replanning. To keep this within limits, increased residual margins are employed. This study aimed to evaluate the proposed automated Online Adaptive Proton Therapy (OAPT) strategies on their capability to reduce the need for manual replanning, while also exploring the possibility of margin reduction. Two automated OAPT methods were examined: Automated Dose Restoration (ADR) and Automated Full Adaptation (AFA). ADR makes use of dose restoration, restoring the original dose map based on the patient's altered anatomy. AFA adapts the contours used for plan optimization by applying a deformation field, not only correcting for density changes, but also for the relative location of organs. A comparative analysis of OAPT strategies, evaluating D 98% tumour coverage on 17 patients, was conducted. The nominal results of non-adapted plans with 7 mm residual margins required manual replanning for 18% of the patients. ADR reduced this to 6%, while AFA eliminated the need for manual replanning. With 2 mm margins, 47% of cases required manual replanning. ADR reduced this to 18%, and AFA further reduced it to 11%. The proposed OAPT strategies offered a marked improvement compared to a non-adaptive approach. ADR and AFA significantly reduced the necessity for manual replanning and facilitated the reduction of residual margins, enhancing dose conformity and reducing treatment toxicity.


21 June 2025 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
PPPieter Populaire
Pieter Populaire
GDGilles Defraene
Gilles Defraene
YLYuting Liu
Yuting Liu
UTUwe Titt
Uwe Titt
PYPablo Yepes
Pablo Yepes
KHKarin Haustermans
Karin Haustermans